GoodRx Holdings (GDRX) Shares Outstanding (2019 - 2025)
GoodRx Holdings (GDRX) has disclosed Shares Outstanding for 7 consecutive years, with $107.1 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding fell 72.03% to $107.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $107.1 million through Dec 2025, down 72.03% year-over-year, with the annual reading at $107.1 million for FY2025, 72.03% down from the prior year.
- Shares Outstanding hit $341.1 million in Q4 2025 for GoodRx Holdings, up from $98.3 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $400.6 million in Q4 2021 to a low of $98.3 million in Q3 2025.
- Historically, Shares Outstanding has averaged $357.7 million across 5 years, with a median of $394.7 million in 2021.
- Biggest five-year swings in Shares Outstanding: soared 71.58% in 2021 and later plummeted 72.03% in 2025.
- Year by year, Shares Outstanding stood at $400.6 million in 2021, then decreased by 0.88% to $397.0 million in 2022, then fell by 0.74% to $394.1 million in 2023, then dropped by 2.86% to $382.8 million in 2024, then tumbled by 72.03% to $107.1 million in 2025.
- Business Quant data shows Shares Outstanding for GDRX at $107.1 million in Q4 2025, $242.9 million in Q3 2025, and $352.8 million in Q2 2025.